RAFAEL POMALES: Open Payments
NPI 1770507493 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 25 payments from 14 companies in 2025. Trend: 2023 $471 · 2024 $846 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $266 |
| AstraZeneca Pharmaceuticals LP | 3 | $222 |
| Exact Sciences Corporation | 4 | $186 |
| Baxter Healthcare | 1 | $150 |
| Madrigal Pharmaceuticals | 3 | $101 |
| Novo Nordisk Inc | 2 | $45 |
| TOLMAR, INC. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $22 |
| Phadia US Inc. | 1 | $20 |
| Cranial Technologies, Inc | 1 | $17 |
Products named: Kerendia, Cologuard Collection Kit, FLOSEAL, LOKELMA, REZDIFFRA, AIRSUPRA, JATENZO, ImmunoCAP.
Industry payments across TX — which companies pay providers there.
